MedTrace Logo

Negative Predictive Value and NIC of Beta-Lactam Antibiotics.

NCT04126096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 747

Last updated 2023-06-22

No results posted yet for this study

Summary

The researchers are trying to evaluate how much medication is required for allergy skin testing and to determine the likelihood that patients with a negative test truly don't have an allergy to the tested drug of skin testing to commonly used antibiotics.

Conditions

  • Allergy

Interventions

DIAGNOSTIC_TEST

Skin Testing beta-lactams

Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.

Sponsors & Collaborators

Principal Investigators

  • Alexei Gonzalez Estrada, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-20
Primary Completion
2023-01-06
Completion
2023-01-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126096 on ClinicalTrials.gov